Liminatus Pharma, Inc. Amends and Restates Merger Agreement with InnocsAI LLC
Liminatus Pharma, Inc. entered into an amended and restated merger agreement with InnocsAI LLC, detailing the terms of the definitive business combination. This development formalizes the strategic plan for Liminatus to acquire InnocsAI's AI healthcare platform.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day